(NYSEMKT: ASXC) Asensus Surgical's forecast annual revenue growth rate of 81.1% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Asensus Surgical's revenue in 2024 is $8,577,000.On average, 1 Wall Street analysts forecast ASXC's revenue for 2024 to be $3,886,685,213, with the lowest ASXC revenue forecast at $3,886,685,213, and the highest ASXC revenue forecast at $3,886,685,213. On average, 1 Wall Street analysts forecast ASXC's revenue for 2025 to be $8,573,010,351, with the lowest ASXC revenue forecast at $8,573,010,351, and the highest ASXC revenue forecast at $8,573,010,351.
In 2026, ASXC is forecast to generate $13,974,659,639 in revenue, with the lowest revenue forecast at $13,974,659,639 and the highest revenue forecast at $13,974,659,639.